Literature DB >> 32717618

Risk of COVID-19 disease in the elderly population and physiotherapy.

Mehmet Özkeskin1, Nuray Elibol2, Serkan Bakırhan2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32717618      PMCID: PMC7266577          DOI: 10.1016/j.physio.2020.05.003

Source DB:  PubMed          Journal:  Physiotherapy        ISSN: 0031-9406            Impact factor:   3.358


× No keyword cloud information.
Dear Editor, COVID-19 occurs with symptoms like fever, cough, myalgia, fatigue, muscle weakness, and impairment in other important bodily functions [1]. As a result of the clinical course of COVID-19 infection, rapidly developing acute respiratory distress syndrome (ARDS) requires intubation and mechanical ventilation (MV) [2]. Comorbid diseases like aging, diabetes mellitus, hypertension, cerebrovascular diseases, chronic respiratory diseases, cancer, etc. along with ARDS were reported to be risk factors for death in patients with COVID-19 [3]. Elderly individuals who are vulnerable to disease are hospitalized in the intensive care unit because they experience the disease more severely and their mortality risk is higher [4]. However, while the health services attempt to prevent patients from dying, early physiotherapy management of COVID-19 patients with ARDS in ICU has been ignored. Studies show that early respiratory physiotherapy of patients with ARDS is an important evidence-based method for the treatment of ARDS. But in the ICU, patients with ARDS are immobilized due to MV or intubation. Immobilization has a dominant effect on diaphragm and limb muscle weakness in patients with critical illness in the ICU [5]. So passive-active mobilization with specific muscle training is required for COVID-19 patients with ARDS in ICU, not only respiratory training. Immobilization, infections, MV and prolonged steroid administration are well-known risk factors for ICU-acquired weakness (ICUAW) which has significant effects not only on patient recovery, and length of ICU stay, but also on rehabilitation in 100% of ICU survivors. Patients with ICUAW develop muscle atrophy, paresis, and reduced deep tendon reflexes which are effective on long-term (after ICU or hospital discharge) rehabilitation management [6]. Rehabilitation after discharge from the ICU is often noticeably slow, particularly in elderly patients. Neuromuscular recovery, especially, is prolonged or incomplete due to exposure to MV for a long time. In the literature, it was reported that up to 65% of these patients have functional limitations after discharge and neuromuscular disorders may continue for many years in some of them [7]. Elderly patients may develop sarcopenia that becomes more severe among those admitted to the ICU due to ARDS and act as a cause or aggravating factor in terms of weakness [8]. We conclude that because of these reasons elderly patients should have early physiotherapy treatment with medical treatment because early physiotherapy will be important for improvement of functional status and quality of life in the elderly in the early period after discharge from the ICU or hospital.

Conflict of interest

None declared.
  7 in total

1.  CrossTalk proposal: Mechanical ventilation-induced diaphragm atrophy is primarily due to inactivity.

Authors:  Scott K Powers; Ashley J Smuder; David Fuller; Sanford Levine
Journal:  J Physiol       Date:  2013-11-01       Impact factor: 5.182

Review 2.  ICU-acquired weakness and recovery from critical illness.

Authors:  John P Kress; Jesse B Hall
Journal:  N Engl J Med       Date:  2014-04-24       Impact factor: 91.245

3.  Sudden and Complete Olfactory Loss of Function as a Possible Symptom of COVID-19.

Authors:  Michael Eliezer; Charlotte Hautefort; Anne-Laure Hamel; Benjamin Verillaud; Philippe Herman; Emmanuel Houdart; Corinne Eloit
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2020-07-01       Impact factor: 6.223

4.  Weakness acquired in the intensive care unit. Incidence, risk factors and their association with inspiratory weakness. Observational cohort study.

Authors:  Ladislao Pablo Diaz Ballve; Nahuel Dargains; José García Urrutia Inchaustegui; Antonella Bratos; Maria de Los Milagros Percaz; Cesar Bueno Ardariz; Sabrina Cagide; Carolina Balestrieri; Claudio Gamarra; Dario Paz; Eliana Rotela; Sebastian Muller; Fernando Bustos; Ricard Aranda Castro; Esteban Settembrino
Journal:  Rev Bras Ter Intensiva       Date:  2017-12-07

5.  Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.

Authors:  Nanshan Chen; Min Zhou; Xuan Dong; Jieming Qu; Fengyun Gong; Yang Han; Yang Qiu; Jingli Wang; Ying Liu; Yuan Wei; Jia'an Xia; Ting Yu; Xinxin Zhang; Li Zhang
Journal:  Lancet       Date:  2020-01-30       Impact factor: 79.321

6.  Clinical Characteristics of Coronavirus Disease 2019 in China.

Authors:  Wei-Jie Guan; Zheng-Yi Ni; Yu Hu; Wen-Hua Liang; Chun-Quan Ou; Jian-Xing He; Lei Liu; Hong Shan; Chun-Liang Lei; David S C Hui; Bin Du; Lan-Juan Li; Guang Zeng; Kwok-Yung Yuen; Ru-Chong Chen; Chun-Li Tang; Tao Wang; Ping-Yan Chen; Jie Xiang; Shi-Yue Li; Jin-Lin Wang; Zi-Jing Liang; Yi-Xiang Peng; Li Wei; Yong Liu; Ya-Hua Hu; Peng Peng; Jian-Ming Wang; Ji-Yang Liu; Zhong Chen; Gang Li; Zhi-Jian Zheng; Shao-Qin Qiu; Jie Luo; Chang-Jiang Ye; Shao-Yong Zhu; Nan-Shan Zhong
Journal:  N Engl J Med       Date:  2020-02-28       Impact factor: 91.245

7.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

Authors:  Fei Zhou; Ting Yu; Ronghui Du; Guohui Fan; Ying Liu; Zhibo Liu; Jie Xiang; Yeming Wang; Bin Song; Xiaoying Gu; Lulu Guan; Yuan Wei; Hui Li; Xudong Wu; Jiuyang Xu; Shengjin Tu; Yi Zhang; Hua Chen; Bin Cao
Journal:  Lancet       Date:  2020-03-11       Impact factor: 79.321

  7 in total
  2 in total

1.  Mental health status of medical staff in Xinjiang Province of China based on the normalisation of COVID-19 epidemic prevention and control.

Authors:  Qiong Wu; Dao Li; Min Yan; Yihua Li
Journal:  Int J Disaster Risk Reduct       Date:  2022-03-28       Impact factor: 4.842

2.  The effects of exercise on COVID-19 therapeutics: A protocol for systematic review and meta-analysis.

Authors:  Zhangmeng Xu; Yong Chen; Duoduo Yu; Dongdong Mao; Ting Wang; Donghong Feng; Tao Li; Shengsong Yan; Yaming Yu
Journal:  Medicine (Baltimore)       Date:  2020-09-18       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.